SCHEMBL7939007

SCHEMBL7939007

C=CCNc1nc(Cl)nc2c(NCC=C)ncnc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
SMN1; SMN2 Q16637 7/20 0.46
KDM4E B2RXH2 7/20 0.46
HPGD P15428 7/20 0.46
LMNA P02545 6/20 0.46
HTT P42858 5/20 0.46
MAPT P10636 5/20 0.46
GAA P10253 2/20 0.46
RAB9A P51151 5/20 0.44
KMT2A Q03164 3/20 0.44
MEN1 O00255 2/20 0.44
HSD17B10 Q99714 5/20 0.44
MAPK1 P28482 2/20 0.44
TP53 P04637 5/20 0.43
NPC1 O15118 4/20 0.43
ALOX15 P16050 3/20 0.43
ALOX12 P18054 2/20 0.43
NFKB1 P19838 1/20 0.43
NFKB2 Q00653 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16105004 0.87 ALDH1A1 (0.54) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHPGD
SCHEMBL16094539 0.80 ALDH1A1 (0.49) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHPGD
SCHEMBL7930938 0.79 LMNA (0.41) KDM4ELMNACDK1
SCHEMBL2685269 0.72 RAB9A (0.49) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHPGD
SCHEMBL7939940 0.71 CHRM4 (0.50) ALDH1A1SMN1; SMN2KDM4EHPGDLMNA
SCHEMBL1936518 0.70 ALDH1A1 (0.71) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHPGD
SCHEMBL20164561 0.70 CYP1A2 (0.44) ALDH1A1L3MBTL1LMNAMAPTGAA
SCHEMBL9049572 0.70 CDK1 (0.50) ALDH1A1L3MBTL1SMN1; SMN2HPGDRAB9A
SCHEMBL7939938 0.69 YTHDC1 (0.49)
SCHEMBL2059480 0.69 SMN1; SMN2 (0.47) ALDH1A1L3MBTL1SMN1; SMN2KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6232312-B1 ADMINISTERING A COMBINATION OF INDENE AND PYRIMIDO(5,4-D)PYRIMIDINE DERIVATIVES TO TREAT PREPANCREATIC CANCER CELL PATHWAYS, INC. 2001-05-15 US disclosed